Lakshmi Digala Nakul Katyal Naureen Narula Raghav Govindarajan
10.3389/fneur.2021.660741
Front Neurol
2021 May 6;12:660741.
aquaporin-4 autoimmune disease complement-inactivating agents eculizumab neuromyelitis optica spectrum disorder relapses seronegative
CC BY
https://pubmed.ncbi.nlm.nih.gov/34025563/
Case Reports
PMC8134535
34025563
Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report
2021